Search Results - Gurdeep Parmar

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma: A phase 1/2 study

    Isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma: A phase 1/2 study by Alexander M. Lesokhin, Richard LeBlanc, Meletios Α. Dimopoulos, Marcelo Capra, Carmelo Carlo‐Stella, Lionel Karlin, Jean‐François Castilloux, Peter A. Forsberg, Gurdeep Parmar, Axel Tosikyan, Luděk Pour, Vincent Ribrag, Rossella Ribolla, Al‐Ola Abdallah, Nadia Le Roux, Liyan Dong, Helgi van de Velde, Laurent Mayrargue, Lucie Lépine, Sandrine Macé, Philippe Moreau

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Isatuximab in Combination with Lenalidomide and Dexamethasone in Patients with High-Risk Smoldering Multiple Myeloma: Updated Safety Run-in Results from the Randomized Phase 3 Ithaca Study

    Isatuximab in Combination with Lenalidomide and Dexamethasone in Patients with High-Risk Smoldering Multiple Myeloma: Updated Safety Run-in Results from the Randomized Phase 3 Itha... by María‐Victoria Mateos, Paula Rodríguez‐Otero, Youngil Koh, Joaquín Martínez‐López, Gurdeep Parmar, H. Miles Prince, Hang Quach, Paz Ribas, Emil Hermansen, Vânia Hungria, Sevgi Kalayoğlu Beşışık, Jin Seok Kim, Xavier Leleu, Valdas Pečeliūnas, Fredrik Schjesvold, Ömür Gökmen Sevindik, Т Е Лаврова, Franck Dubin, Christine Devisme, Lucie Lepine, Sandrine Macé, Mony Morisse, Irene M. Ghobrial

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: